Medrx Co. Ltd.

Medrx Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY140.53
Market Cap
JPY7.22 B
Shares Outstanding
12.71 M
Public Float
8.66 M

Profile

Address
431-7 Nishiyama
Higashikagawa Kagawa 769
Japan
Employees -
Website http://www.medrx.co.jp
Updated 07/08/2019
Medrx Co. Ltd. engages in the business of pharmaceutical drug development based on the transdermal absorption. It develops new value-added medicines by the drug formulation technology based on ILTS (Ionic Liquid Transdermal System), a unique technologies using ionic liquid. The company was founded by Masayoshi Matsumura on January 15, 2002 and is headquartered in Higashikagawa, Japan.

Financials

View All
Created with Highcharts 5.0.14Medrx Co. Ltd.Net Income. Fiscal year is January-December. All values JPY Thousands.621 997621 9971 016 5471 016 547878 366878 3661 259 0811 259 081884 387884 3871 267 6861 267 6862013201420152016201720180250k500k750k1 000k1 250k1 500k
Created with Highcharts 5.0.14Medrx Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values JPY Thousands.68 57568 57526 28526 28537 61237 61222 34122 341198 212198 2128 3978 397201320142015201620172018050k100k150k200k250k

Masayoshi Matsumura
Chairman
Yonehiro Matsumura
President & Representative Director